Adult population MigraMax is indicated for the treatment of migraine-associated symptoms such as headache, nausea and vomiting.
For the treatment and prevention of athlete's foot.
The Swedish Medical Products Agency acting as reference member state through the European Decentralised Procedure has approved a new oral...
The European Commission has granted marketing authorization for Raplixa (sealant powder), from The Medicines Co., for use as a haemostatic...
Teva Pharmaceuticals Industries Ltd., announced that the FDA has accepted for review the company�s new drug application (NDA) for albuterol...
Teva Pharmaceutical Industries Ltd., announced that the FDA approved two products for adolescent and adult patients with asthma. These products,...
The FDA has accepted for review the supplemental new drug application (sNDA) for ProAir RespiClick (albuterol sulfate) Inhalation Powder, from...
The Purpose of this study is to assess the efficacy and safety of three strengths of the FF/GW642444 Inhalation Powder in subject with Chronic Obstructive Pulmonary Disease (COPD)
Hyaluronidase can be used to enhance permeation of subcutaneous or intramuscular injections, local anaesthetics and subcutaneous infusions and to promote resorption of excess fluids and blood in the tissues.